ADC Therapeutics SA
NYSE:ADCT
Cash Flow Statement
Cash Flow Statement
ADC Therapeutics SA
Sep-2019 | Dec-2019 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||||||||
Net Income |
(142)
|
(116)
|
(237)
|
(226)
|
(246)
|
(298)
|
(200)
|
(252)
|
(230)
|
(195)
|
(187)
|
(166)
|
(156)
|
(199)
|
(181)
|
(179)
|
(240)
|
|
Depreciation & Amortization |
1
|
2
|
2
|
2
|
2
|
3
|
2
|
3
|
3
|
3
|
3
|
3
|
2
|
2
|
3
|
3
|
1
|
|
Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(26)
|
(30)
|
(34)
|
(34)
|
(1)
|
2
|
(1)
|
(2)
|
37
|
|
Stock-Based Compensation |
0
|
1
|
12
|
23
|
38
|
52
|
59
|
62
|
60
|
60
|
55
|
55
|
49
|
44
|
32
|
19
|
13
|
|
Other Non-Cash Items |
(1)
|
0
|
92
|
71
|
64
|
59
|
(19)
|
30
|
46
|
42
|
41
|
76
|
83
|
110
|
114
|
65
|
37
|
|
Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
1
|
1
|
1
|
9
|
11
|
13
|
14
|
2
|
(3)
|
0
|
|
Cash Interest Paid |
0
|
0
|
0
|
2
|
2
|
3
|
4
|
4
|
5
|
7
|
11
|
15
|
21
|
27
|
27
|
28
|
0
|
|
Change in Working Capital |
(6)
|
(7)
|
4
|
2
|
12
|
12
|
7
|
(5)
|
(26)
|
(32)
|
(29)
|
(25)
|
(66)
|
(34)
|
(36)
|
(25)
|
46
|
|
Cash from Operating Activities |
(148)
N/A
|
(122)
+18%
|
(139)
-14%
|
(151)
-9%
|
(169)
-12%
|
(224)
-33%
|
(209)
+7%
|
(223)
-7%
|
(233)
-4%
|
(212)
+9%
|
(207)
+2%
|
(146)
+29%
|
(137)
+7%
|
(118)
+14%
|
(102)
+14%
|
(138)
-36%
|
(119)
+14%
|
|
Investing Cash Flow | ||||||||||||||||||
Capital Expenditures |
(4)
|
(2)
|
(1)
|
(2)
|
(3)
|
(3)
|
(6)
|
(7)
|
(6)
|
(7)
|
(5)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
|
Other Items |
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
|
Cash from Investing Activities |
(4)
N/A
|
(2)
+43%
|
(1)
+57%
|
(2)
-141%
|
(3)
-21%
|
(3)
-23%
|
(6)
-64%
|
(7)
-16%
|
(7)
-1%
|
(7)
-12%
|
(5)
+29%
|
(3)
+39%
|
(3)
+22%
|
(2)
+17%
|
(2)
-15%
|
(3)
-17%
|
(3)
-14%
|
|
Financing Cash Flow | ||||||||||||||||||
Net Issuance of Common Stock |
101
|
102
|
244
|
436
|
433
|
433
|
189
|
(2)
|
1
|
1
|
1
|
6
|
6
|
0
|
0
|
0
|
1
|
|
Net Issuance of Debt |
(1)
|
(1)
|
62
|
62
|
62
|
61
|
49
|
268
|
267
|
267
|
217
|
(6)
|
(7)
|
(6)
|
69
|
70
|
73
|
|
Cash from Financing Activities |
101
N/A
|
101
0%
|
306
+205%
|
498
+63%
|
495
-1%
|
495
0%
|
238
-52%
|
266
+12%
|
267
+1%
|
267
+0%
|
218
-19%
|
1
-100%
|
(1)
N/A
|
(1)
+10%
|
74
N/A
|
70
-6%
|
74
+6%
|
|
Change in Cash | ||||||||||||||||||
Effect of Foreign Exchange Rates |
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
Net Change in Cash |
(51)
N/A
|
(23)
+55%
|
166
N/A
|
345
+107%
|
324
-6%
|
268
-17%
|
23
-91%
|
36
+54%
|
27
-24%
|
48
+75%
|
5
-90%
|
(149)
N/A
|
(140)
+6%
|
(120)
+14%
|
(29)
+76%
|
(70)
-141%
|
(48)
+32%
|
|
Free Cash Flow | ||||||||||||||||||
Free Cash Flow |
(152)
N/A
|
(124)
+18%
|
(139)
-13%
|
(153)
-10%
|
(172)
-12%
|
(227)
-33%
|
(215)
+5%
|
(230)
-7%
|
(240)
-4%
|
(219)
+9%
|
(212)
+3%
|
(149)
+30%
|
(139)
+7%
|
(120)
+14%
|
(104)
+13%
|
(141)
-35%
|
(122)
+13%
|